Hepatology International

Hepatology International

国际肝病学

  • 2区 中科院分区
  • Q1 JCR分区

期刊简介

《Hepatology International》是由Springer India出版社于2007年创办的英文国际期刊(ISSN: 1936-0533,E-ISSN: 1936-0541),该期刊长期致力于胃肠肝病学领域的创新研究,主要研究方向为胃肠肝病学-医学。作为SCIE收录期刊(JCR分区 Q1,中科院 2区),本刊采用OA未开放获取模式(OA占比0.1507...%),以发表胃肠肝病学领域等方向的原创性研究为核心(研究类文章占比92.50%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在120篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Hepatology International审稿周期约为 较慢,6-12周 。该刊近年未被列入国际预警名单,年发文量约120篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 120 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
3区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
2区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q1 22 / 143

85%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q1 21 / 143

85.66%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:10.9 SJR:1.813 SNIP:1.467
学科类别 分区 排名 百分位
大类:Medicine 小类:Hepatology Q1 14 / 82

83%

期刊发文

  • Laparoscopic and open liver resection for hepatocellular carcinoma with type 2 diabetes mellitus: multicenter propensity score-matched study

    Author: Yang, Shi-Ye; Feng, Jin-Kai; Yan, Mao-Lin; Guo, Lei; Duan, Yun-Fei; Ye, Jia-Zhou; Liu, Zong-Han; Xiang, Yan-Jun; Xu, Li; Xue, Jie; Shi, Jie; Lau, Wan Yee; Cheng, Shu-Qun; Guo, Wei-Xing

    Journal: HEPATOLOGY INTERNATIONAL. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s12072-023-10492-2

  • Messenger RNA electroporated hepatitis B virus (HBV) antigen-specific T cell receptor (TCR) redirected T cell therapy is well-tolerated in patients with recurrent HBV-related hepatocellular carcinoma post-liver transplantation: results from a phase I trial

    Author: Yang, Fan; Zheng, Xiaofang; Koh, Sarene; Lu, Jianxi; Cheng, Jintao; Li, Panlong; Du, Cong; Chen, Yunhao; Chen, Xiaoyan; Yang, Li; Chen, Wanxin; Wong, Regina Wanju; Wai, Lu-En; Wang, Tingting; Zhang, Qi; Chen, Wenjie

    Journal: HEPATOLOGY INTERNATIONAL. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s12072-023-10524-x

  • OHCCPredictor: an online risk stratification model for predicting survival duration of older patients with hepatocellular carcinoma

    Author: Tan, Juntao; Yu, Yue; Lin, Xiantian; He, Yuxin; Jin, Wen; Qian, Hong; Li, Ying; Xu, Xiaomei; Zhao, Yuxi; Ning, Jianwen; Zhang, Zhengyu; Chen, Jingjing; Wu, Xiaoxin

    Journal: HEPATOLOGY INTERNATIONAL. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s12072-023-10516-x

  • miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression

    Author: Qiu, Jiannan; Wu, Shasha; Wang, Peng; Zhou, Yan; Wang, Zhongxia; Sun, Yong; Jiang, Chunping

    Journal: HEPATOLOGY INTERNATIONAL. 2023; Vol. 17, Issue 2, pp. 463-475. DOI: 10.1007/s12072-022-10404-w

  • The association between visceral adipocyte hypertrophy and NAFLD in subjects with different degrees of adiposity

    Author: Sun, Haixiang; Fang, Da; Wang, Hongdong; Wang, Jin; Yuan, Yue; Huang, Shanshan; Ma, Huayang; Gu, Tianwei; Bi, Yan

    Journal: HEPATOLOGY INTERNATIONAL. 2023; Vol. 17, Issue 1, pp. 215-224. DOI: 10.1007/s12072-022-10409-5

  • Effects of antiviral therapy and drug withdrawal on postpartum hepatitis in pregnant women with chronic HBV infection

    Author: Li, Minghui; Sun, Fangfang; Bi, Xiaoyue; Lin, Yanjie; Yang, Liu; Jiang, Tingting; Deng, Wen; Lu, Yao; Zhang, Lu; Yi, Wei; Xie, Yao

    Journal: HEPATOLOGY INTERNATIONAL. 2023; Vol. 17, Issue 1, pp. 42-51. DOI: 10.1007/s12072-022-10412-w

  • N-terminal propeptide of type 3 collagen-based sequential algorithm can identify high-risk steatohepatitis and fibrosis in MAFLD

    Author: Tang, Liang-Jie; Li, Gang; Eslam, Mohammed; Zhu, Pei-Wu; Chen, Sui-Dan; Leung, Howard Ho-Wai; Huang, Ou-Yang; Wong, Grace Lai-Hung; Zhou, Yu-Jie; Karsdal, Morten; Leeming, Diana Julie; Jiang, Pei; Wang, Cong; Yuan, Hai-Yang; Byrne, Christopher D.; Targher, Giovanni; George, Jacob; Wong, Vincent Wai-Sun; Zheng, Ming-Hua

    Journal: HEPATOLOGY INTERNATIONAL. 2023; Vol. 17, Issue 1, pp. 190-201. DOI: 10.1007/s12072-022-10420-w

  • Metabolic dysfunction-associated fatty liver disease and liver function markers are associated with Crohn's disease but not Ulcerative Colitis: a prospective cohort study

    Author: Chen, Jie; Dan, Lintao; Tu, Xinru; Sun, Yuhao; Deng, Minzi; Chen, Xuejie; Hesketh, Therese; Li, Ran; Wang, Xiaoyan; Li, Xue

    Journal: HEPATOLOGY INTERNATIONAL. 2023; Vol. 17, Issue 1, pp. 202-214. DOI: 10.1007/s12072-022-10424-6